Changes for page Customer segments in Health and Wellbeing Living Labs
Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.11
edited by Sarantis Dimitriadis
on 2022/06/07 10:26
on 2022/06/07 10:26
Change comment:
There is no comment for this version
To version 6.1
edited by Sarantis Dimitriadis
on 2023/05/30 09:33
on 2023/05/30 09:33
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -106,11 +106,8 @@ 106 106 (% class="western" lang="en-GB" %) 107 107 (% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table . 108 108 109 -(% style="margin-left:auto; margin-right:auto" %) 110 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)((( 111 -(% class="western" lang="en-GB" style="text-align:center" %) 112 -(% lang="en-US" %)**Age or age group** 113 -))) 109 +(% style="height:1004px; margin-left:auto; margin-right:auto; width:1694px" %) 110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups** 114 114 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 115 115 (% lang="en-US" %)Specific age range 116 116 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( ... ... @@ -122,145 +122,47 @@ 122 122 (% class="western" %) 123 123 124 124 ))) 125 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 126 -(% class="western" lang="en-GB" %) 127 -(% lang="en-US" %)Elderly 128 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 129 -(% class="western" lang="en-GB" %) 130 -(% lang="en-US" %)Adults 131 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 132 -(% class="western" lang="en-GB" %) 133 -(% lang="en-US" %)Youth 134 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 135 -(% class="western" lang="en-GB" %) 136 -(% lang="en-US" %)Children 137 -))) 122 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)General Population 138 138 |(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 139 139 (% class="western" %) 140 140 141 141 ))) 142 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 143 -(% class="western" lang="en-GB" style="text-align:center" %) 144 -(% lang="en-US" %)**Health status** 145 -))) 127 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)** 146 146 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 147 147 (% class="western" lang="en-GB" %) 148 148 (% lang="en-US" %)Healthy 149 149 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 150 150 (% class="western" lang="en-GB" %) 151 - (%lang="en-US" %)Patient133 + 152 152 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 153 153 (% class="western" lang="en-GB" %) 154 - (%lang="en-US" %)Rehabilitant136 + 155 155 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 156 156 (% class="western" lang="en-GB" %) 157 - (%lang="en-US" %)Recovered/Survivor139 + 158 158 ))) 159 159 |(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 160 160 (% class="western" %) 161 161 162 162 ))) 163 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 164 -(% class="western" lang="en-GB" style="text-align:center" %) 165 -(% lang="en-US" %)**A specific disease, disorder or disability** 166 -))) 167 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 168 -(% class="western" lang="en-GB" %) 169 -(% lang="en-US" %)ADHD 170 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 171 -(% class="western" lang="en-GB" %) 172 -(% lang="en-US" %)Dementia 173 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 174 -(% class="western" lang="en-GB" %) 175 -(% lang="en-US" %)Parkinsons’ disease 176 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 177 -(% class="western" lang="en-GB" %) 178 -(% lang="en-US" %)Loneliness and Social Isolation 179 -))) 180 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 181 -(% class="western" lang="en-GB" %) 182 -(% lang="en-US" %)Autism 183 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 184 -(% class="western" lang="en-GB" %) 185 -(% lang="en-US" %)Down syndrome 186 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 187 -(% class="western" lang="en-GB" %) 188 -(% lang="en-US" %)Physical disability 189 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 190 -(% class="western" lang="en-GB" %) 191 -(% lang="en-US" %)Mental health 192 -))) 193 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 194 -(% class="western" lang="en-GB" %) 195 -(% lang="en-US" %)Cardiovascular disease 196 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 197 -(% class="western" lang="en-GB" %) 198 -(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF) 199 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 200 -(% class="western" lang="en-GB" %) 201 -(% lang="en-US" %)Sleep apnea/apnea 202 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 203 -(% class="western" lang="en-GB" %) 204 -(% lang="en-US" %)Mild cognitive impairment 205 -))) 206 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 207 -(% class="western" lang="en-GB" %) 208 -(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD) 209 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 210 -(% class="western" lang="en-GB" %) 211 -(% lang="en-US" %)Language disability 212 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 213 -(% class="western" lang="en-GB" %) 214 -(% lang="en-US" %)Substance abuse (drugs, alcohol) 215 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 216 -(% class="western" lang="en-GB" %) 217 -(% lang="en-US" %)Multiple sclerosis 218 -))) 219 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 220 -(% class="western" lang="en-GB" %) 221 -(% lang="en-US" %)Cognitive disorder (mild, major) 222 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 223 -(% class="western" lang="en-GB" %) 224 -(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation 225 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 226 -(% class="western" lang="en-GB" %) 227 -(% lang="en-US" %)Trauma patient 228 - 229 -(% class="western" lang="en-GB" %) 230 -(% lang="en-US" %)(e.g., a spinal cord injury) 231 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 232 -(% class="western" lang="en-GB" %) 233 -(% lang="en-US" %)Neurodegenerative diseases 234 -))) 145 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)** 146 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Schizophrenia|Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Parkinson Disease 147 +|Post-Stroke Patients with Moving or Linguistic Disability|Mild Cognitive Impairment|Sleep Disorders: e.g., Apnea, Hypopnea|With Disability 148 +|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) 235 235 |(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 236 236 (% class="western" %) 237 237 238 238 ))) 239 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 240 -(% class="western" lang="en-GB" style="text-align:center" %) 241 -(% lang="en-US" %)**Clients of a specific service** 242 -))) 243 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 244 -(% class="western" lang="en-GB" %) 245 -(% lang="en-US" %)Child welfare 246 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 247 -(% class="western" lang="en-GB" %) 248 -(% lang="en-US" %)Nursing home 249 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 250 -(% class="western" lang="en-GB" %) 251 -(% lang="en-US" %)Employment service 252 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 153 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)** 154 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Parkinson Disease|Mild Cognitive Impairment|With Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 253 253 (% class="western" %) 254 254 255 255 ))) 256 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((158 +|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 257 257 (% class="western" lang="en-GB" %) 258 - (%lang="en-US" %)Early childhood education160 + 259 259 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 260 260 (% class="western" lang="en-GB" %) 261 -(% lang="en-US" %)Home care 262 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 263 -(% class="western" lang="en-GB" %) 264 264 265 265 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 266 266 (% class="western" lang="en-GB" %) ... ... @@ -270,70 +270,20 @@ 270 270 (% class="western" %) 271 271 272 272 ))) 273 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 274 -(% class="western" lang="en-GB" style="text-align:center" %) 275 -(% lang="en-US" %)**Vulnerable groups** 276 -))) 277 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 172 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)** 173 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 278 278 (% class="western" lang="en-GB" %) 279 -(% lang="en-US" %)Minors/Children 280 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 281 -(% class="western" lang="en-GB" %) 282 -(% lang="en-US" %)Single parents with minor children 283 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 284 -(% class="western" lang="en-GB" %) 285 -(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence 286 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 287 -(% class="western" lang="en-GB" %) 288 -(% lang="en-US" %)Substance users 289 - 290 -(% class="western" lang="en-GB" %) 291 -(% lang="en-US" %)(drugs, alcohol) 175 +Down Syndrome 292 292 ))) 293 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 294 294 (% class="western" lang="en-GB" %) 295 -(% lang="en-US" %)Disabled people 296 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 297 -(% class="western" lang="en-GB" %) 298 -(% lang="en-US" %)Victims of trafficking in human beings 299 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 300 -(% class="western" lang="en-GB" %) 301 -(% lang="en-US" %)Ethnic minorities and immigrants 302 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 303 -(% class="western" lang="en-GB" %) 304 -(% lang="en-US" %)Isolated people 305 -))) 306 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 307 -(% class="western" lang="en-GB" %) 308 -(% lang="en-US" %)Elderly people 309 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 310 -(% class="western" lang="en-GB" %) 311 -(% lang="en-US" %)Persons with serious illnesses 312 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 313 -(% class="western" lang="en-GB" %) 314 -(% lang="en-US" %)Homeless people 315 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 316 -(% class="western" lang="en-GB" %) 317 -(% lang="en-US" %)Ex-prisoners and people with criminal background 318 -))) 319 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; text-align:left; vertical-align:middle; width:153px" %)((( 320 -(% class="western" lang="en-GB" %) 321 -(% lang="en-US" %)Pregnant women 322 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 323 -(% class="western" lang="en-GB" %) 324 -(% lang="en-US" %)Persons with mental disorders 325 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 326 -(% class="western" lang="en-GB" %) 327 327 328 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 329 -(% class="western" lang="en-GB" %) 330 - 331 331 ))) 332 332 333 333 : 334 334 335 335 (% class="western" lang="en-GB" %) 336 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) 185 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) . 337 337 338 338 |**Researcher expertise**|**Brief use case description** 339 339 |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making